VV116 Noninferior to Nirmatrelvir-Ritonavir for COVID-19
Noninferiority established with respect to time to sustained clinical recovery for adults at high risk for progression
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.